SEC Form 4 · accession 0001127602-17-031653
MERIDIAN BIOSCIENCE INC · VIVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vecheslav A Elagin
Officer — EVP, R&D & Chf Scientific Off
Period of report
Nov 7, 2017
Accepted (ET)
Nov 9, 2017 · 9:25 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000794172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 7, 2017 | F | 4,437 | $14.6175 | D | 48,489 | D | |
| Common Stock | holding | — | — | — | 80 | I | Held in Meridian Savings & Investment Plan (401K) |
Table II — derivative securities
No Table II lines on this filing.